Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of two intervention strategies for depressive disorders in oncology patients
2006-002880-19Phase 4Active
- Sponsor
- Hospital Universitario La Paz
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of escitalopram in major depressive disorder (MDD) (2 arms), sponsored by Hospital Universitario La Paz. Primary endpoints: Depressive symptomatology change at 12 weeks, Depressive symptomatology change at 24 weeks and 3 more. Started Jul 2006; status: active.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2006-002880-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002880-19.